Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$0
1:22cv66 • January 18, 2022
Class Period Start
June 1, 2021
Class Period End
November 4, 2021
PSLRA Deadline
March 21, 2022
Case Allegations
10b5
Statutes of Repose
Jun 1, 2024
Country
United States
Court
Federal Court
Jun 13, 2022
Voluntary Dismissal
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Apr 20, 2022
Scheduling Order
Apr 6, 2022
Appointment of Lead Plaintiff
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Jan 18, 2022
First Filed Complaint
A securities fraud class action complaint has been filed on behalf of certain investors in NRX Pharmaceuticals, Inc..
TOP
